Pfizer to grant Rs 65 lakh to innovating Oncology and Digital Health Startups Leave a comment
Pfizer to grant Rs 65 lakh to innovating Oncology and Digital Health Startups
New Delhi, April 8 (KNN) The leading biopharmaceutical company Pfizer will grant Rs 65 lakh to three startups in Oncology and Digital Health under its INDovation Programme which is a part of its CSR initiatives.
The version 2.0 of the programme was jointly launched by Atal Innovation Mission, NITI Aayog, AGNIi, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi, Pfizer and Social Alpha to support breakthrough healthcare innovations by startups in India.
During the first year of this programme, three winning startups from the Oncology and Digital Health segment will receive a funding of upto Rs 65 lakh each for product trials, pilot studies, and product market launches to accelerate the lab-to-market journey of their innovation.
The access to their entire network of incubators and facilities via co-incubation for startups will be provided by AIM and NITI Aayog .
Both the bodies will also provide technical and strategic advisory to support to both the program and the startups.
The Indian Institute of Technology, Delhi (IIT Delhi), will be the principal incubation partner while customised incubation support will be provided across technology incubation centers such as the IITs, other major technology institutes and incubation network of Atal Innovation Mission across India.
Social Alpha, as the implementation partner, will support startups to accelerate their lab-to-market journey.
In the early version, Pfizer successfully incubated 9 healthcare innovators and supported 19 IP filings.
The programme is also being supported by AGNIi, PATH, AHPI, St Johns Research Institute, HCG Hospitals, Cytecare Hospitals, FICCI, UNHIEX, Google for Startups, Design Alpha, HIMSS, Marico Innovation Foundation, and TenX2. (KNN Bureau)
